Shopping cart ITEMS
 modern scholarly publishers in the finest tradition
Login Register
Home
Books
Journals
References
A-Z Index
Author Index
For Our Authors
User Area
Shopping Cart
Contact
Electronic Data Center

Critical Reviews™ in Eukaryotic Gene Expression

 

ISSN for PRINT: 1045-4403

Institutional price:

$708.00

Issues per year:

4

For Online Access

Best Paper Award Selection - Editorial Board Site

Add subscription to shopping cart

2002, Volume12

Issue 3

  78 pages  

DOI: 10.1615/CritRevEukaryotGeneExpr.v12.i3   

click 'Save as...' here to save XML metadata

Issue price - $169.00  

Add to shopping cart

  • Scaffolds for Tissue Engineering of Cartilage
  • T. B. F. Woodfield
    IsoTis N.V., PO Box 98, 3720 MB Bilthoven, The Netherlands, and Institute for Biomedical Technology, University of Twente, PO Box 217, 7500 AE Enschede, The Netherlands

    J. M. Bezemer
    IsoTis N.V., PO Box 98, 3720 MB Bilthoven, The Netherlands

    J. S. Pieper
    IsoTis N.V., PO Box 98, 3720 MB Bilthoven, The Netherlands

    C. A. van Blitterswijk
    IsoTis N.V., PO Box 98, 3720 MB Bilthoven, The Netherlands, and Institute for Biomedical Technology, University of Twente, PO Box 217, 7500 AE Enschede, The Netherlands

    J. Riesle
    IsoTis N.V., PO Box 98, 3720 MB Bilthoven, The Netherlands


    ABSTRACT

    Articular cartilage lesions resulting from trauma or degenerative diseases are commonly encountered clinical problems. It is well-established that adult articular cartilage has limited regenerative capacity, and, although numerous treatment protocols are currently employed clinically, few approaches exist that are capable of consistently restoring long-term function to damaged articular cartilage. Tissue engineering strategies that focus on the use of three-dimensional scaffolds for repairing articular cartilage lesions offer many advantages over current treatment strategies. Appropriate design of biodegradable scaffold conduits (either preformed or injectable) allow for the delivery of reparative cells, bioactive factors, or gene factors to the defect site in an organized manner. This review seeks to highlight pertinent design considerations and limitations related to the development, material selection, and processing of scaffolds for articular cartilage tissue engineering, evidenced over the last decade. In particular, considerations for novel repair strategies that use scaffolds in combination with controlled release of bioactive factors or gene therapy are discussed, as are scaffold criteria related to mechanical stimulation of cell-seeded constructs. Furthermore, the subsequent impact of current and future aspects of these multidisciplinary scaffold-based approaches related to in vitro and in vivo cartilage tissue engineering are reported herein.

    DOI: 10.1615/CritRevEukaryotGeneExpr.v12.i3.40

    Download article, 28 pages

    Article price - $35.00  

    Add to shopping cart

    << Previous article  

    Designed by offsiteteam Designed by offsiteteam Designed by offsiteteam
    Begell House Inc.
    50 Cross Highway,
    Redding, CT 06896
    TEL (203) 938 1300
    FAX (203) 938 1304
    orders@begellhouse.com